Literature DB >> 21365646

Impact of intracellular alpha fetoprotein on retinoic acid receptors-mediated expression of GADD153 in human hepatoma cell lines.

Chaoying Li1, Shanshan Wang, Wei Jiang, Hui Li, Zhongmin Liu, Chao Zhang, Michael A McNutt, Gang Li.   

Abstract

The aim of our study was to gain a better understanding of the molecular mechanism underlying the previously unrecognized role of cytoplasmic alpha fetoprotein (AFP) in retinoic acid receptors (RAR) mediated expression and biological effects of GADD153. Using microarray analysis, the expression of the GADD153 gene showed the greatest fold change among apoptosis/growth related genes in response to ATRA. AFP was able to interact with RAR in HepG2 cells, which was undetectable in HLE cells owing to absence of AFP. ATRA promoted nuclei entrance of RAR, expression of GADD153 and apoptosis, and these changes were reversed after transfection with the afp gene or addition of AGN193109. The level of GADD153 was gradually elevated as the effect of AFP was counteracted by increasing dose or prolonging treatment time with ATRA in HepG2 cells. Knockdown of AFP in siRNA-transfected HepG2 cells or over-expression of AFP in afp gene-transfected HLE cells was synchronously associated with up-regulation or down-regulation, respectively, of GADD153 expression. Both ATRA administration and AFP knockdown were each able to promote greater binding of RAR to its response element with consequent elevation of the proportion of apoptotic cells. Conversely, transfection of HLE cells with pcDNA3.1-afp resulted in apparent reduction of RAR binding to DNA and change of biological effect. These data taken together demonstrate the involvement of AFP in RAR-mediated expression and biological effects of GADD153. These findings provide a novel insight into the mechanism underlying the impact of AFP on the RAR signal network.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365646     DOI: 10.1002/ijc.26025

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.

Authors:  Peng Li; Shan-Shan Wang; Hui Liu; Ning Li; Michael A McNutt; Gang Li; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2015-07-12

3.  Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells.

Authors:  Haipeng Feng; Bo Lin; Yifei Zheng; Junnv Xu; Ying Zhou; Kun Liu; Mingyue Zhu; Mengsen Li
Journal:  Cell J       Date:  2020-07-18       Impact factor: 2.479

4.  The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2016-07-22

5.  Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.

Authors:  Mingyue Zhu; Junli Guo; Hua Xia; Wei Li; Yan Lu; Xu Dong; Yi Chen; Xieju Xie; Shigan Fu; Mengsen Li
Journal:  Oncoscience       Date:  2015-01-06

6.  Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.

Authors:  Gerald J Mizejewski
Journal:  J Hepatocell Carcinoma       Date:  2016-09-21

7.  Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.

Authors:  Chao Zhang; Hui Li; Wei Jiang; Xiaowei Zhang; Gang Li
Journal:  Oncotarget       Date:  2016-12-13

8.  Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro.

Authors:  Mingyue Zhu; Wei Li; Yan Lu; Xu Dong; Yi Chen; Bo Lin; Xieju Xie; Junli Guo; Mengsen Li
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

Review 9.  Emerging therapies in advanced hepatocellular carcinoma.

Authors:  Sowmini Medavaram; Yue Zhang
Journal:  Exp Hematol Oncol       Date:  2018-08-03

10.  AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.

Authors:  Tianke Chen; Xiaowei Dai; Juji Dai; Chaodong Ding; Zheng Zhang; Ziqi Lin; Jin Hu; Mei Lu; Zhanyu Wang; Yalei Qi; Li Zhang; Rulu Pan; Zhu Zhao; Liting Lu; Wanqin Liao; Xincheng Lu
Journal:  Cell Death Dis       Date:  2020-10-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.